ONTOLOGY REPORT - ANNOTATIONS
Term: cetrorelix
Accession: CHEBI:59224
browse the term
Definition: A synthetic ten-membered oligopeptide comprising N-acetyl-3-(naphthalen-2-yl)-D-alanyl, 4-chloro-D-phenylalanyl, 3-(pyridin-3-yl)-D-alanyl, L-seryl, L-tyrosyl, N(5)-carbamoyl-D-ornithyl, L-leucyl, L-arginyl, L-prolyl, and D-alaninamide residues coupled in sequence. A gonadotrophin-releasing hormone (GnRH) antagonist, it is used for treatment of infertility and of hormone-sensitive cancers of the prostate and breast.
Synonyms: exact_synonym: N-acetyl-3-(naphthalen-2-yl)-D-alanyl-4-chloro-D-phenylalanyl-3-(pyridin-3-yl)-D-alanyl-L-seryl-L-tyrosyl-N(5)-carbamoyl-D-ornithyl-L-leucyl-L-arginyl-L-prolyl-D-alaninamide
related_synonym: C70H92ClN17O14; CC(C)C[C@H](NC(=O)[C@@H](CCCNC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@@H](Cc1cccnc1)NC(=O)[C@@H](Cc1ccc(Cl)cc1)NC(=O)[C@@H](Cc1ccc2ccccc2c1)NC(C)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C)C(N)=O; InChI=1S/C70H92ClN17O14/c1-39(2)31-52(61(94)82-51(15-9-28-77-69(73)74)68(101)88-30-10-16-58(88)67(100)79-40(3)59(72)92)83-60(93)50(14-8-29-78-70(75)102)81-63(96)54(34-43-20-25-49(91)26-21-43)86-66(99)57(38-89)87-65(98)56(36-45-11-7-27-76-37-45)85-64(97)55(33-42-18-23-48(71)24-19-42)84-62(95)53(80-41(4)90)35-44-17-22-46-12-5-6-13-47(46)32-44/h5-7,11-13,17-27,32,37,39-40,50-58,89,91H,8-10,14-16,28-31,33-36,38H2,1-4H3,(H2,72,92)(H,79,100)(H,80,90)(H,81,96)(H,82,94)(H,83,93)(H,84,95)(H,85,97)(H,86,99)(H,87,98)(H4,73,74,77)(H3,75,78,102)/t40-,50-,51+,52+,53-,54+,55-,56-,57+,58+/m1/s1; InChIKey=SBNPWPIBESPSIF-MHWMIDJBSA-N; cetrorelixum
xref_casrn: 120287-85-6
xref: Beilstein:5860649 "Beilstein Registry Number"; ChEMBL:774441 "ChEMBL COMPOUND"; ChemIDplus:120287-85-6 "CAS Registry Number"; DrugBank:DB00050 "DrugBank"; KEGG DRUG:D07665 "KEGG DRUG"
xref_mesh: MESH:C062876
xref: Patent:EP299402 "Patent"; Patent:US4800191 "Patent"; Wikipedia:Cetrorelix "Wikipedia"
cetrorelix
G
Apoe
apolipoprotein E
multiple interactions
ISO
1
79,003,634
79,006,387
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
increases expression
ISO
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bax
Bcl2-associated X protein
increases expression
EXP
1
95,933,023
95,938,176
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
decreases expression
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
3
143,129,087
143,180,199
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
ISO
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp3
caspase 3
increases activity
EXP
16
48,944,226
48,962,420
RGD:6480464
CTD
G
Casp9
caspase 9, apoptosis-related cysteine peptidase
increases activity
ISO
5
160,704,234
160,721,796
RGD:6480464
CTD
G
Casp9
caspase 9, apoptosis-related cysteine peptidase
increases activity
EXP
5
160,704,234
160,721,796
RGD:6480464
CTD
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
20
7,376,325
7,386,778
RGD:6480464
CTD
G
Chga
chromogranin A (parathyroid secretory protein 1)
multiple interactions
ISO
RGD:6480464
CTD
G
Clcf1
cardiotrophin-like cytokine factor 1
decreases expression
ISO
1
206,802,745
206,806,332
RGD:6480464
CTD
G
Cst9l
cystatin 9-like
multiple interactions
ISO
3
137,601,785
137,604,598
RGD:6480464
CTD
G
Cxcl12
chemokine (C-X-C motif) ligand 12
decreases expression
ISO
4
153,503,576
153,516,423
RGD:6480464
CTD
G
Cyb5a
cytochrome b5 type A (microsomal)
multiple interactions
ISO
18
81,415,972
81,452,606
RGD:6480464
CTD
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
multiple interactions
ISO
8
61,793,976
61,805,308
RGD:6480464
CTD
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
multiple interactions
ISO
1
251,965,458
251,971,449
RGD:6480464
CTD
G
Ddr1
discoidin domain receptor tyrosine kinase 1
multiple interactions
ISO
20
3,194,265
3,214,611
RGD:6480464
CTD
G
Dhcr24
24-dehydrocholesterol reductase
multiple interactions
ISO
5
127,637,438
127,662,621
RGD:6480464
CTD
G
Dpep3
dipeptidase 3
multiple interactions
ISO
19
35,814,990
35,820,643
RGD:6480464
CTD
G
Fas
Fas (TNF receptor superfamily, member 6)
increases expression
ISO
1
238,259,443
238,274,745
RGD:6480464
CTD
G
Fas
Fas (TNF receptor superfamily, member 6)
increases expression
EXP
1
238,259,443
238,274,745
RGD:6480464
CTD
G
Fshb
follicle stimulating hormone, beta polypeptide
decreases expression
ISO
3
92,569,344
92,571,254
RGD:6480464
CTD
G
Fshb
follicle stimulating hormone, beta polypeptide
decreases expression
EXP
3
92,569,344
92,571,254
RGD:6480464
CTD
G
Gsta2
glutathione S-transferase alpha 2
multiple interactions
ISO
8
83,299,249
83,312,958
RGD:6480464
CTD
G
Hcrtr1
hypocretin (orexin) receptor 1
decreases expression
EXP
5
149,160,739
149,170,736
RGD:6480464
CTD
G
Hcrtr2
hypocretin (orexin) receptor 2
decreases expression
EXP
8
81,068,303
81,196,608
RGD:6480464
CTD
G
Hmgcs2
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial)
multiple interactions
ISO
2
193,128,736
193,143,106
RGD:6480464
CTD
G
Hsd17b6
hydroxysteroid (17-beta) dehydrogenase 6
multiple interactions
ISO
7
1,118,183
1,137,670
RGD:6480464
CTD
G
Igf1
insulin-like growth factor 1
decreases expression
ISO
7
24,531,669
24,605,742
RGD:6480464
CTD
G
Il6
interleukin 6
decreases expression
ISO
4
456,799
461,376
RGD:6480464
CTD
G
Insl3
insulin-like 3
multiple interactions
ISO
16
18,890,131
18,891,475
RGD:6480464
CTD
G
Lhb
luteinizing hormone beta
decreases expression
EXP
1
95,892,999
95,893,988
RGD:6480464
CTD
G
Lhb
luteinizing hormone beta
decreases expression
ISO
1
95,892,999
95,893,988
RGD:6480464
CTD
G
Lhb
luteinizing hormone beta
decreases expression
ISO
1
95,892,999
95,893,988
RGD:6480464
CTD
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation
ISO
11
85,968,732
86,030,387
RGD:6480464
CTD
G
Mapk3
mitogen activated protein kinase 3
decreases phosphorylation
ISO
1
185,935,044
185,941,245
RGD:6480464
CTD
G
Msmo1
methylsterol monooxygenase 1
multiple interactions
ISO
16
26,698,324
26,716,247
RGD:6480464
CTD
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
multiple interactions
ISO
1
236,592,414
236,677,379
RGD:6480464
CTD
G
Pgrmc1
progesterone receptor membrane component 1
multiple interactions
ISO
X
8,265,543
8,273,667
RGD:6480464
CTD
G
Prl
prolactin
decreases expression
EXP
17
44,699,101
44,709,162
RGD:6480464
CTD
G
Prok1
prokineticin 1
multiple interactions
ISO
2
202,707,628
202,712,886
RGD:6480464
CTD
G
Prps2
phosphoribosyl pyrophosphate synthetase 2
multiple interactions
ISO
X
47,274,362
47,315,274
RGD:6480464
CTD
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
ISO
1
208,262,669
208,273,148
RGD:6480464
CTD
G
Rhob
ras homolog family member B
multiple interactions
ISO
6
32,052,333
32,054,507
RGD:6480464
CTD
G
Star
steroidogenic acute regulatory protein
multiple interactions
ISO
16
70,642,580
70,647,203
RGD:6480464
CTD
G
Stat3
signal transducer and activator of transcription 3 (acute-phase response factor)
decreases phosphorylation
ISO
10
89,821,078
89,872,970
RGD:6480464
CTD
G
Sycp1
synaptonemal complex protein 1
multiple interactions
ISO
2
197,989,614
198,164,611
RGD:6480464
CTD
G
Taf4b
TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa
multiple interactions
ISO
18
6,071,848
6,168,486
RGD:6480464
CTD
G
Tex19.2
testis expressed gene 19.2
multiple interactions
ISO
10
110,325,885
110,353,003
RGD:6480464
CTD
G
Tgfb1
transforming growth factor, beta 1
decreases expression
ISO
1
80,894,705
80,911,020
RGD:6480464
CTD
G
Tnfsf13
tumor necrosis factor (ligand) superfamily, member 13
decreases expression
ISO
10
56,499,945
56,502,928
RGD:6480464
CTD
G
Tp53
tumor protein p53
increases expression
ISO
10
56,399,721
56,411,150
RGD:6480464
CTD
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
9
10,520,730
10,536,071
RGD:6480464
CTD
G
Wisp2
WNT1 inducible signaling pathway protein 2
multiple interactions
ISO
3
154,748,977
154,760,324
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest